本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aura Biosciences, Inc.

6.80
+0.24243.70%
成交量:13.10万
成交额:87.58万
市值:4.22亿
市盈率:-3.58
高:6.86
开:6.56
低:6.53
收:6.56
数据加载中...
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933